The use of synthetic peptides in the goal of developing a new, inexpensive vaccine against hepatitis A virus is one of the encouraging approaches followed by many laboratories. These peptides have to be well characterized, being their physicochemical properties one of the most relevant points to con
Interaction of the Hepatitis A peptide VP3(110–121) with lipid mono and bilayer models of cellular membranes
✍ Scribed by C. Mestres; M. A. Alsina; J. A. Pérez; F. Reig; I. Haro
- Publisher
- Springer
- Year
- 1997
- Weight
- 496 KB
- Volume
- 275
- Category
- Article
- ISSN
- 0340-255X
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
In the present work the pattern of miscibility between a hepatitis A virus (HAV) synthetic peptide (AcVP3110) with monolayers composed of lipids of different charge was studied. Zwitterionic (dipalmitoyl phosphatidylcholine (DPPC)), anionic (dipamitoyl phosphatidylglycerol (DPPG)), and cationic (ste
## Abstract This article addresses the interactions of the synthetic antimicrobial peptide dermaseptin 01 (GLWSTIKQKGKEAAIAAA‐ KAAGQAALGAL‐NH~2~, DS 01) with phospholipid (PL) monolayers comprising (i) a lipid‐rich extract of __Leishmania amazonensis__ (LRE‐La), (ii) zwitterionic PL (dipalmitoylpho
Synthetic peptide vaccines are safer and cheaper than classical ones, but immunoresponse is usually lower. The early interaction of hepatitis A virus (HAV) with cells during the infection and immunological response processes is not as well-known as for other picornavirus. However, it seems that elec
Model membranes with unsaturated lipid chains containing various amounts of M13 coat protein in the e-helical form were studied using time-resolved fluorescence and ESR spectroscopy. The lipid-to-protein (L/P) ratios used were > 12 to avoid protein-protein contacts and irreversible aggregation leadi